NCT06174155

Brief Summary

PURPOSE: The study aims to compare study between Botulinum toxin-A injection and shock waves therapy on hypertrophic scars in hand-burned children. BACKGROUND: Burn injuries can cause significant physical and psychological distress, especially when they result in hypertrophic scarring. In children, who are particularly vulnerable to these injuries, it is important to accurately assess the severity of these scars and their impact on functionality. HYPOTHESES: There is no significant difference between the combined effect of the traditional physical therapy program with botulinum toxin-A injection and the traditional physical therapy program with shock waves therapy on improving wrist extension, ulnar deviation, radial deviation, hand grip strength, and severity of the scar on hypertrophic scars in hand-burned children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2024

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2025

Completed
Last Updated

February 4, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 8, 2023

Last Update Submit

February 2, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Electronic goniometer

    to assess the range of motions of wrist extension, radial deviation, and ulnar deviation. Active ROM Measurement: the patient independently moving their affected joint. The device records the joint angle throughout the movement, allowing for a thorough assessment of functional limitations caused by hypertrophic scars. Passive ROM Measurement: the therapist moves the patient's joint through its range of motion while the electronic goniometer measures and records the joint angles. This approach provides valuable information about the degree of movement restriction due to hypertrophic scarring.

    3 months

  • Hand grip Dynamometer

    for hand grip strength is used for assessing upper limb impairment, work capacity following injury or disease, and rehabilitation progression and/or potential following injury or surgery. For each child, the maximal voluntary contraction was determined as the highest of three contractions (INITIAL MAX). After a one-minute rest period, children will be instructed to squeeze the dynamometer in a static contraction at a level of 50% maximal for as long as possible, the duration of which will be recorded (DURATION). The level of static contraction will be monitored by the assessor who provided verbal feedback to ensure that a level of 50% maximal was maintained. Children must perform an additional post-fatigue maximal contraction within 10 seconds of completing the 50% maximal static contraction (FINAL MAX).

    3 months

  • Vancouver scar scale

    It employs four main parameters to evaluate hypertrophic scars: vascularity, pigmentation, pliability, and height. These parameters are individually scored on a scale ranging from 0 to 3, with higher scores indicating greater severity. The scores are then summed to provide an overall measure of scar severity, ranging from 0 (normal skin) to 14 (most severe scar). To ensure accurate evaluations, it is recommended to have adequate lighting, a calm environment, and reliable observers trained in using the VSS. Evaluators carefully assess each parameter, considering factors such as erythema, texture, and skin tension to assign appropriate scores. Finally, the total score provides a comprehensive representation of the hypertrophic scar's severity.

    3 months

Study Arms (3)

Control group

ACTIVE COMPARATOR

The control group will receive the physical therapy program and conduct five times per week over four consecutive weeks under the supervision of a physical rehabilitation specialist.

Other: physical therapy treatment

Study group A

ACTIVE COMPARATOR

The study group A will receive Botulinum toxin-A injection in addition to physical therapy program as control group

Other: Botulinum toxin-A injection in addition to physical therapy program

Study group B

ACTIVE COMPARATOR

The study group B will receive shock wave therapy in addition to physical therapy program as control group.

Other: shock wave therapy in addition to physical therapy program

Interventions

The control group will receive the physical therapy program and conduct five times per week over four consecutive weeks under the supervision of a physical rehabilitation specialist. The primary focus of the program was to improve scar malleability, lengthen muscles and tendons, enhance joint mobility, and to restore functionality. Each session lasted almost for 45 minutes and consisted of therapeutic paraffin application; deep tissue massaging (5 minutes); stretching exercises; active ROM exercises.

Control group

Two injection procedures will be used. The first is an EMG-guided BTX-A administration (Botox®, Allergan PLC, Dublin, Ireland) that will be localized to the motor endplate zone of the wrist flexors, radial and ulnar deviators. The second is a meso-injection procedure, where the BTX-A will be injected subdermal, intradermal, and into the scar (around the periphery and into the center).

Study group A

After wound and skin graft healing (\~ 90 days post-surgery), the unfocused shockwave will be applied to the site of burn injury on the volar aspect of the hand of the subjects and will allocate to the shock wave therapy intervention arm. The treatment will be delivered using a portable shockwave device (Zimmer enPuls, EMS physio Ltd, Germany).

Study group B

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age will range from 6-18 years
  • Diagnosed with hypertrophic scars resulting from hand burns.
  • Has burn injuries caused by flame, scald or chemical agents.
  • With a total body surface area (TBSA) varied from 10 to 30%
  • A resistant partial or complete loss of wrist flexion attributable to wrist flexor contracture
  • After wound and skin graft healing (\~ 90 days post-surgery),

You may not qualify if:

  • Children with underlying medical conditions that could interfere with scar healing or treatment outcomes
  • Skin flap surgery, malignancies, cardiac arrhythmias, pacemaker implantation, coagulopathies, fractures about the treatment area, articular adhesions, and psychiatric co-morbidities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reham Alsakhawi

Giza, 11236, Egypt

Location

MeSH Terms

Interventions

Physical Therapy ModalitiesBotulinum Toxins, Type AExtracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationBotulinum ToxinsMetalloendopeptidasesEndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesMetalloproteasesBacterial ProteinsProteinsAmino Acids, Peptides, and ProteinsBacterial ToxinsToxins, BiologicalBiological FactorsUltrasonic TherapyDiathermyHyperthermia, Induced

Study Officials

  • Reham Alsakhawi

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 18, 2023

Study Start

December 15, 2023

Primary Completion

March 5, 2024

Study Completion

June 20, 2025

Last Updated

February 4, 2026

Record last verified: 2025-12

Locations